Commentaries question benefit of early breast cancer screening

October 14, 2003

A series of three commentaries in the October 15 issue of the Journal of the National Cancer Institute address the issue of whether premenopausal women are being accurately informed about the potential harms versus benefits of mammography before undergoing screening.

In the first commentary, Cornelia J. Baines, M.D., of the University of Toronto, notes that randomized trials of breast cancer screening have consistently found that for women ages 40 to 49, screened women have a higher rate of death from breast cancer than unscreened women for up to 11 years after screening starts--only then do benefits appear.

"Women are supposed to be informed before making decisions about screening, but unfortunately, most are ill-informed about both the hazards and the benefits of screening," Baines writes.

She offers possible biologic explanations for the higher mortality rates among younger women treated for breast cancer, such as the stimulation of dormant metastases after surgery and the low-energy x-rays used in screening mammography, which some believe are more likely to cause cancer than high-energy x-rays.

Baines says more concrete answers should be available after publication of results from a U.K. trial of mammography screening, which recruited women as they turned 40 years old.

In a counterpoint to the commentary, Alfred O. Berg, M.D., writing on behalf of the U.S. Preventive Services Task Force, points out that the evidence suggesting an early mortality increase is weak and its real importance is unknown.

Still, he cautions, screening in premenopausal women may have important harms, including false-positive results, unnecessary biopsies, and possible overdiagnosis and overtreatment of cases that might not have been clinically important.

"Thus, whether screening actually reduces survival for a very small number of younger women may or may not outweigh the value women place on the benefit of the modest reduction in long-term risk and the much higher likelihood of less serious, but nonetheless important, harms," says Berg, of the University of Washington, Seattle.

Baines agrees with this latter point, adding that she hopes the commentaries will prompt others to investigate the causes of the puzzling observation. In the meantime, she says, "women should carefully consider whether screening is the right choice for them. They cannot do that until they are completely informed."
-end-
Contact: Janet Wong, University of Toronto, 416-978-5949, fax: 416-978-7430, jf.wong@utoronto.ca; Pam Sowers, University of Washington, 206-543-3620; fax: 206-616-9080, sowerspl@u.washington.edu.

Baines CJ. Mammography screening: Are women really giving informed consent? J Natl Cancer Inst 2003;95:1508-11.

Berg AO. Mammography screening: Are women really giving informed consent? (Counterpoint) J Natl Cancer Inst 2003;95:1511-12.

Baines CJ. Mammography screening: Are women really giving informed consent? (Countering the Counterpoint) J Natl Cancer Inst 2003;95:1512-13.

Note: The Journal of the National Cancer Institute is published by Oxford University Press and is not affiliated with the National Cancer Institute. Attribution to the Journal of the National Cancer Institute is requested in all news coverage.

Journal of the National Cancer Institute

Related Breast Cancer Articles from Brightsurf:

Oncotarget: IGF2 expression in breast cancer tumors and in breast cancer cells
The Oncotarget authors propose that methylation of DVDMR represents a novel epigenetic biomarker that determines the levels of IGF2 protein expression in breast cancer.

Breast cancer: AI predicts which pre-malignant breast lesions will progress to advanced cancer
New research at Case Western Reserve University in Cleveland, Ohio, could help better determine which patients diagnosed with the pre-malignant breast cancer commonly as stage 0 are likely to progress to invasive breast cancer and therefore might benefit from additional therapy over and above surgery alone.

Partial breast irradiation effective treatment option for low-risk breast cancer
Partial breast irradiation produces similar long-term survival rates and risk for recurrence compared with whole breast irradiation for many women with low-risk, early stage breast cancer, according to new clinical data from a national clinical trial involving researchers from The Ohio State University Comprehensive Cancer Center - Arthur G.

Breast screening linked to 60 per cent lower risk of breast cancer death in first 10 years
Women who take part in breast screening have a significantly greater benefit from treatments than those who are not screened, according to a study of more than 50,000 women.

More clues revealed in link between normal breast changes and invasive breast cancer
A research team, led by investigators from Georgetown Lombardi Comprehensive Cancer Center, details how a natural and dramatic process -- changes in mammary glands to accommodate breastfeeding -- uses a molecular process believed to contribute to survival of pre-malignant breast cells.

Breast tissue tumor suppressor PTEN: A potential Achilles heel for breast cancer cells
A highly collaborative team of researchers at the Medical University of South Carolina and Ohio State University report in Nature Communications that they have identified a novel pathway for connective tissue PTEN in breast cancer cell response to radiotherapy.

Computers equal radiologists in assessing breast density and associated breast cancer risk
Automated breast-density evaluation was just as accurate in predicting women's risk of breast cancer, found and not found by mammography, as subjective evaluation done by radiologists, in a study led by researchers at UC San Francisco and Mayo Clinic.

Blood test can effectively rule out breast cancer, regardless of breast density
A new study published in PLOS ONE demonstrates that Videssa® Breast, a multi-protein biomarker blood test for breast cancer, is unaffected by breast density and can reliably rule out breast cancer in women with both dense and non-dense breast tissue.

Study shows influence of surgeons on likelihood of removal of healthy breast after breast cancer dia
Attending surgeons can have a strong influence on whether a patient undergoes contralateral prophylactic mastectomy after a diagnosis of breast cancer, according to a study published by JAMA Surgery.

Young breast cancer patients undergoing breast conserving surgery see improved prognosis
A new analysis indicates that breast cancer prognoses have improved over time in young women treated with breast conserving surgery.

Read More: Breast Cancer News and Breast Cancer Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.